Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Background. When combined with ceftazidime, the novel non–β-lactam β-lactamase inhibitor avibactam provides a carbapenem alternative against multidrug-resistant infections. Efficacy and safety of ceftazidime-avibactam plus metronidazole were compared with meropenem in 1066 men and women with complic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazuski, John E., Gasink, Leanne B., Armstrong, Jon, Broadhurst, Helen, Stone, Greg G., Rank, Douglas, Llorens, Lily, Newell, Paul, Pachl, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872289/
https://www.ncbi.nlm.nih.gov/pubmed/26962078
http://dx.doi.org/10.1093/cid/ciw133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872289/
https://www.ncbi.nlm.nih.gov/pubmed/26962078
http://dx.doi.org/10.1093/cid/ciw133

Ejemplares similares